Study guide
4.4 Lab Measures & Related Medical Terms in MTM
PTCB Medication Therapy Management Certificate Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts & Format 1.2 Eligibility, Application & Testing 1.3 Pharmacy Technician Role in MTM 1.4 Domain Weights & Study Strategy
2 Chapter 2: Medication Product Knowledge
2.1 Strengths, Doses, and Drug Classes 2.2 Dosage Forms, Routes, and Administration Instructions 2.3 Storage, Special Handling, and Duration of Therapy 2.4 Interchangeable Classes and Forms for Cost Savings
3 Chapter 3: Terminology & History Collection
3.1 Patient-Friendly Medical Terminology 3.2 Medication Allergy vs Medication Intolerance 3.3 Adherence Definitions in Medication History 3.4 Medical History Components for MTM
4 Chapter 4: Medication-Related Problems & Labs
4.1 Common Medication-Related Problems Overview 4.2 Side Effects, Adverse Drug Reactions & Allergies in MTM 4.3 Nonadherence, Affordability Barriers & Gaps in Therapy 4.4 Lab Measures & Related Medical Terms in MTM
5 Chapter 5: Adherence Calculations
5.1 Days’ Supply, Quantity, and Dose 5.2 Proportion of Days Covered (PDC) 5.3 PQA Threshold & Star Ratings Adherence Measures
6 Chapter 6: Documentation Accuracy Reviews
6.1 Personal Medication Record (PMR) Accuracy Review 6.2 MAP and CMR Documentation Accuracy 6.3 MTM Billing Fields Accuracy Checks
7 Chapter 7: Prescribing Errors & Therapy Conflicts
7.1 Types of Prescribing Errors 7.2 Inappropriate Prescribing & Duplicate Therapy 7.3 Drug Interactions & Conflicting Therapies 7.4 Impact of Prescribing Errors & Medication Problems
8 Chapter 8: High-Risk Medications in Older Adults
8.1 2023 AGS Beers Criteria: High-Risk Medications in Older Adults 8.2 STOPP/START Concepts & Anticholinergic Burden in MTM Screening 8.3 High-Alert & Narrow Therapeutic Index Awareness for MTM Tech Support
9 Chapter 9: MTM Core Elements
9.1 Purpose of MTM & Five Core Elements 9.2 Medication Therapy Review (MTR) 9.3 Personal Medication Record (PMR) 9.4 Medication-Related Action Plan (MAP)
10 Chapter 10: Intervention, Documentation & CMS Rules
10.1 Intervention, Referral & Follow-Up 10.2 MTM Documentation Standards 10.3 CMS Part D MTM Targeting Requirements
11 Chapter 11: CMR, TMR, Billing & Workflow
11.1 Comprehensive Medication Review (CMR) 11.2 Targeted Medication Review (TMR) 11.3 CPT Billing Codes for MTM (99605 / 99606 / 99607) 11.4 Workflow Prioritization, Stages & Timelines
4.4 Lab Measures & Related Medical Terms in MTM
Key Takeaways Explain This Topic AI
A1C reflects average glycemia over about three months; ADA generally targets <7% for most non-pregnant adults, with individualization
Serum potassium is typically about 3.5–5.0 mEq/L; hypo- and hyperkalemia have cardiac and muscular risks tied to diuretics, ACE inhibitors/ARBs, and supplements
Blood pressure targets commonly referenced in modern adult care include <130/80 mm Hg for most adults per the 2025 AHA/ACC high blood pressure guideline, which kept the threshold set in 2017
Technicians gather and organize labs and home readings for pharmacist assessment—they do not independently intensify therapy based on a single number
Related terms (INR, eGFR/CrCl, LDL) appear throughout MTM; know plain-language meanings and when abnormal values become MRP flags
Last updated: August 2026
Lab Measures & Related Medical Terms in MTM
Quick Answer: Know what A1C , serum potassium , and blood pressure measure, typical target or reference ranges used in adult care, and how abnormal results become effectiveness or safety MRP flags. Technicians collect and organize these data; pharmacists interpret and act.
Lab and vital-sign literacy is part of Domain 1 medical concepts. You will not calculate every clinical nuance on the exam, but you must recognize the measures named in the outline and connect them to common drug therapy problems.
A1C (Hemoglobin A1C)
A1C estimates average blood glucose over roughly the prior three months by measuring glycated hemoglobin. It is the cornerstone monitoring lab for diabetes MTM reviews.
- Concept Practical detail
- What it measures Average glycemia (~3 months)
- General ADA target <7% for most non-pregnant adults
Individualization Older adults or those with comorbidities may have higher individualized targets (for example, <7.5% in some cases); selected patients may aim lower if hypoglycemia risk is low
- Poor control signal Values around 9% or higher often indicate need for regimen review/intensification
- Patient-friendly phrase "A blood test that shows your average blood sugar over about three months"
- MTM use of A1C
A1C above goal on current therapy → effectiveness MRP / possible needs-additional-therapy after pharmacist assessment (example: A1C 9.2% on metformin monotherapy).
Improving A1C after a prior intervention → document response at follow-up.
Very low A1C with intensive regimens → pharmacist reviews hypoglycemia risk; technicians should surface any patient reports of shaking, sweating, confusion, or low meter readings.
Scenario — A1C Flag
Packet shows A1C 9.2%, medication list metformin only, diagnosis type 2 diabetes. Tech: Attach lab, note monotherapy + elevated A1C for pharmacist; do not tell the patient which drug to add. Pharmacist lens: Ineffective therapy / needs additional therapy candidates per guidelines.
Serum Potassium
Potassium is a critical electrolyte for heart rhythm and muscle function.
- Status Approximate adult range Clinical concern
- Normal About 3.5–5.0 mEq/L Reference window used on many exams and panels
- Hypokalemia Below ~3.5 mEq/L Weakness, cramps, arrhythmia risk; QT prolongation association
- Hyperkalemia Above ~5.0 mEq/L Peaked T waves, dangerous arrhythmias, cardiac arrest risk
- Drug connections technicians should recognize
Loop and thiazide diuretics can lower potassium (hypokalemia risk).
ACE inhibitors, ARBs, and potassium-sparing diuretics (spironolactone, eplerenone, amiloride) can raise potassium.
Potassium chloride supplements plus ACE inhibitor/ARB therapy can precipitate hyperkalemia —classic heart-failure regimen watch point (furosemide + lisinopril + KCl).
Technician role: if a recent potassium is available, place it next to the ACE inhibitor/ARB/diuretic/supplement list. If the patient reports muscle weakness, palpitations, or "heart skipping" on these regimens, escalate promptly with the lab context.
Patient-friendly phrasing: "Potassium is a mineral in your blood that helps your heart and muscles work. Your water pills and blood pressure pills can change it, so we watch the number."
Blood Pressure
Blood pressure (BP) is a vital sign, not a serum lab, but the PTCB outline groups it with measures technicians encounter in MTM.
Item High-yield fact
Modern adult target (2025 AHA/ACC) <130/80 mm Hg for most adults (unchanged from the 2017 guideline it replaced)
Why it matters in MTM Effectiveness of antihypertensives; adherence to RAS antagonists; safety (hypotension, dizziness)
- Home logs Encourage dated readings; bring logs to CMR
- Patient-friendly term "Blood pressure" / "high blood pressure" for hypertension
- How technicians use BP data
Readings consistently above goal on therapy → flag for pharmacist effectiveness/adherence review.
New dizziness after a dose increase → safety concern (possible hypotension).
Missing BP med fills + high home readings → combined adherence and effectiveness story.
Do not independently tell the patient to double doses based on one high reading. Organize the data; escalate the pattern.
Related Labs and Terms You Will See Beside the Big Three
- Term Plain meaning Why MTM cares
- INR How "thin" the blood is on warfarin NTI monitoring; high INR → bleed risk; low → clot risk
- eGFR Estimate of kidney filtering Dose adjustments; drug safety in CKD
- Creatinine / CrCl Kidney function markers; CrCl often via Cockcroft-Gault Dosing in older adults
- LDL-C "Bad" cholesterol fraction Statin effectiveness; ASCVD risk discussions
- BMP / CMP Basic/comprehensive metabolic panels Electrolytes, kidney, glucose context
- Hypoglycemia Low blood sugar Safety with insulin/secretagogues
- Hyperglycemia High blood sugar Effectiveness / adherence concerns
You do not need to memorize every reference range for every analyte, but you should recognize that kidney function labs change drug safety , INR drives warfarin MRPs , and lipids support statin gap/effectiveness reviews .
Turning Numbers into MRP Flags (Without Practicing Medicine)
Use a consistent attachment habit when preparing CMR/TMR packets:
Pull the most recent A1C, potassium, creatinine/eGFR, INR (if on warfarin), and BP logs available.
Place them next to the related drugs (diabetes meds, ACE inhibitor/ARB/diuretics/K supplements, warfarin, antihypertensives, statins).
Write a one-line observation, not a prescription: "A1C 9.2% on metformin only—flag for pharmacist," "K 5.4 on lisinopril + KCl—flag for pharmacist," "Home BP 158/92 with late losartan fills—flag for pharmacist."
Escalate verbally when values or symptoms suggest urgency (very high potassium symptoms, signs of bleeding with high INR, symptomatic hypoglycemia).
Scenario — Connecting Lab + Regimen
Patient on lisinopril and potassium chloride; latest potassium 5.6 mEq/L; patient notes "heart flutter." Tech: Immediate pharmacist alert; provide lab and medication list; advise patient not to take extra potassium products meanwhile pending pharmacist/prescriber guidance. MRP lane: Safety (hyperkalemia risk).
Scenario — BP + Adherence
Home log shows most readings ≥150/90; losartan last filled 40 days ago for a 30-day supply. Tech: Flag therapy lapse + uncontrolled BP readings for pharmacist adherence and effectiveness review.
Plain-Language Lab Explanations for Patient Documents
When drafting patient-facing notes (pharmacist-approved), prefer:
- A1C → average blood sugar test over about three months
- Potassium → blood mineral that affects heart and muscles
- Blood pressure → the force of blood in your arteries; high numbers raise stroke and heart risk
- INR → blood test that checks how thin your blood is on warfarin
- eGFR → estimate of how well your kidneys filter
Avoid dumping unexplained abbreviations onto the MAP. Keep precise numbers in the clinical packet; keep actions on the MAP concrete ("Bring your home blood pressure log to your next visit").
Quick Reference Card for Exam Day
- Measure Remember
- A1C ~3-month average glucose; general target <7% ; ≥9% often poor control
- Potassium ~ 3.5–5.0 mEq/L ; ACEI/ARB/K-sparing ↑ K; loops/thiazides ↓ K
- Blood pressure Many adults targeted to <130/80 (AHA/ACC 2025)
- Technician job Gather, organize, flag— pharmacist interprets and intervenes
Lab measures turn silent problems into visible MRPs. When you reliably attach A1C, potassium, and blood pressure data to the right medications, you shorten the pharmacist's path from "something feels off" to a documented effectiveness or safety intervention—and you demonstrate exactly the medical-concept skill the PTCB MTM outline expects.